Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Gastrointestinal 2Breast 2Plasma cell 1Other hematologic neoplasm 1Other 1Genitourinary 1Dermatologic 1

Conditions

Multiple Myeloma 155Lymphoma 20Recurrence 17Neoplasms 12Hematologic Neoplasms 11Neoplasms, Plasma Cell 9Lymphoma, Non-Hodgkin 9Immunoglobulin Light-chain Amyloidosis 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myelodysplastic Syndromes 5Lymphoma, Mantle-Cell 5Leukemia, Myeloid, Acute 5Hodgkin Disease 5Smoldering Multiple Myeloma 4Prostatic Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Plasma Cell 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia 4Breast Neoplasms 4Ovarian Neoplasms 3Melanoma 3Lymphoma, B-Cell, Marginal Zone 3Lung Neoplasms 3Cytokine Release Syndrome 3Waldenstrom Macroglobulinemia 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Primary Myelofibrosis 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fatigue × Plasma cell × 30 days × Clear all
NCT07102212 2026-05-18

FOCUS

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
120 enrolled
BreastDermatologicGenitourinaryPlasma cellThoracic

Alzheimer Disease, Anxiety Disorders, Breast Neoplasms, Depression, Fatigue, Lung Neoplasms, Melanoma, Multiple Myeloma, Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡